Mohs surgery is a precise technique for removing skin cancer one thin layer at a time, checking each layer under a microscope before deciding whether to take more. This approach removes the entire tumor while sparing as much healthy skin as possible, making it the gold standard for skin cancers in areas where preserving tissue matters most. It’s performed in a single visit, typically under local anesthesia, and most patients go home the same day.
How the Procedure Works
The core idea behind Mohs is simple: remove a little, check it, and only remove more if cancer remains. After numbing the area with local anesthetic, the surgeon cuts a thin layer of tissue around the visible tumor. That tissue is carefully placed on blotting paper, keeping its exact orientation intact so the surgeon knows precisely where each piece came from on your body.
The specimen is then color-coded with ink at specific positions (think of a clock face: marks at 3, 6, 9, and 12 o’clock) and drawn onto a detailed map. A technician processes the tissue into frozen sections, and the surgeon personally examines the slides under a microscope, looking at the entire underside and edges of the removed tissue. If cancer cells remain in any section, the surgeon marks that spot on the map in red and removes another thin layer only from that specific area. The process repeats until every margin is clear.
This map-and-check cycle is called a “stage.” Most cases are straightforward: 54% of surgeries need just one stage, and another 35.5% are complete after two. Only about 10% of cases require three or more rounds. Each stage takes roughly 30 to 60 minutes of waiting while the tissue is processed, so the total visit can range from a few hours to most of the day depending on the tumor’s size and depth.
Why It Preserves More Tissue
In a standard skin cancer excision, the surgeon removes the tumor along with a predetermined margin of healthy-looking skin on all sides, then sends it to a separate lab. A pathologist checks a sampling of the edges days later. If cancer cells are found at the margin, a second surgery may be needed.
Mohs flips this process. Because the surgeon examines 100% of the tissue margin in real time, the tumor can be chased precisely to its edges rather than estimated with wide safety margins. For melanoma cases treated with a specialized staining technique, roughly 82% of tumors were fully removed with margins of 6 millimeters or less, often narrower than what standard excision guidelines recommend. That difference of a few millimeters may sound small, but on a nose, eyelid, or lip, it can mean the difference between a simple closure and a complex reconstruction.
Which Cancers It Treats
Mohs is most commonly used for basal cell carcinoma and squamous cell carcinoma, the two most frequent skin cancers. It’s considered especially appropriate when these tumors appear in sensitive locations: the central face, eyelids, nose, lips, ears, temples, genitalia, hands, feet, and around the nipples. These are areas where tissue conservation matters for both function and appearance.
Beyond location, several other factors make Mohs the preferred approach. Tumors that have come back after prior treatment, cancers with aggressive growth patterns, tumors in previously irradiated skin, and cases in patients with immune suppression or genetic syndromes that predispose to skin cancer all meet criteria for Mohs. For tumors on the trunk and extremities, Mohs is typically reserved for these higher-risk scenarios rather than used as a first-line option.
The technique also works for a range of less common skin cancers, including dermatofibrosarcoma protuberans, Merkel cell carcinoma, sebaceous carcinoma, and extramammary Paget disease, among others. For melanoma in situ and certain invasive melanomas, Mohs can be performed using a specialized immunostaining method that highlights melanoma cells on the tissue slides. In a study of over 1,400 primary melanomas treated this way, the local recurrence rate was just 0.49%, with a five-year disease-specific survival rate above 98%.
Closing the Wound
Once the margins are clear, the surgeon decides how to close the wound based on its size, depth, and location. There are several options, and the choice is tailored to give the best functional and cosmetic result.
In a study of nearly 1,000 Mohs cases, the breakdown looked like this:
- Simple linear closure (stitching the edges together): 39% of cases, the most common and associated with smaller defects
- Local skin flaps (repositioning nearby skin to cover the wound): about 40% combined, including advancement, rotation, and transposition flaps
- Skin grafts (transplanting skin from another body site): 10%
- Second intention healing (letting the wound heal on its own without closure): about 3%
In rare cases, roughly 1 in 300, the patient is referred to a plastic surgeon or oculoplastic surgeon for reconstruction of a particularly complex defect. Most of the time, the Mohs surgeon handles the repair in the same visit.
What to Expect on Surgery Day
Mohs is an outpatient procedure. You’ll be awake the entire time, with the surgical site numbed by local anesthetic. The biggest surprise for most patients is the waiting: after each layer is removed, you sit in the office (often with a temporary bandage) while the tissue is processed and examined. Bring a book, phone charger, or snacks. Plan to be there for at least a few hours, and keep your schedule clear for the full day in case additional stages are needed.
Pain during the procedure is generally minimal because of the anesthetic. Afterward, you can expect some soreness, swelling, and bruising around the surgical site. Activity restrictions depend on the location and complexity of the repair, but most people are told to avoid strenuous exercise and heavy lifting for at least one to two weeks to prevent bleeding or stress on the stitches. Sutures are typically removed within 5 to 14 days, depending on the body site.
Insurance and Cost
Medicare and most private insurers cover Mohs surgery when it meets medical necessity criteria. The Centers for Medicare and Medicaid Services maintain specific guidelines listing which diagnoses, tumor types, and anatomical locations qualify. Basal cell and squamous cell carcinomas in the face, hands, feet, and genitalia are straightforwardly covered. Tumors on the trunk and extremities generally need an additional qualifying factor, such as recurrence, aggressive features, or prior radiation to the area, for coverage to apply. Rarer skin cancers like dermatofibrosarcoma protuberans and Merkel cell carcinoma are covered regardless of location.
The total cost varies depending on how many stages are required and what type of reconstruction is needed. Because each stage and the repair are billed separately, a straightforward one-stage case with a simple closure costs significantly less than a four-stage case requiring a complex flap. If you have insurance, your out-of-pocket cost depends on your plan’s deductible and co-insurance structure. Verifying coverage and getting a cost estimate from the surgeon’s office before your procedure is a practical step that avoids surprises.